Jonathan Chrispin, M.D., is an Associate Professor of Medicine in the Johns Hopkins Medicine Division of Cardiology, Electrophysiology and Arrhythmia, as well as an Associate Professor of Biomedical Engineering at Johns Hopkins University. Dr. Chrispin focuses on all aspects of clinical electrophysiology, including pacemaker/defibrillator implantation and complex catheter ablation for atrial and ventricular arrhythmias. Dr. Chrispin received his Bachelor of Arts degree from Harvard University. He received his Doctor of Medicine degree from Vanderbilt University. He completed intern and residency training in internal medicine at The Johns Hopkins Hospital, where he also completed a fellowship in cardiovascular disease and served as chief clinical cardiac electrophysiology fellow. He is a member of the American College of Cardiology, the American Heart Association, and the Heart Rhythm Society. Dr. Chrispin directs the Ventricular Arrhythmia Ablation and Research program, focusing on using advanced cardiac imaging to better understand the structural substrate associated with the development of ventricular arrhythmias and using artificial intelligence to improve the risk stratification of sudden cardiac death. Further, he is involved in developing clinical trials to improve the safety and efficacy of catheter ablation for the treatment of ventricular tachycardia. His work has led to Dr. Chrispin publishing in a number of international journals, including Circulation, the Journal of the American College of Cardiology, Heart Rhythm Journal, Nature Cardiovascular Research, Journal of the American Heart Association, and EP Europace. Dr. Chrispin is rated as an Elite provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Ventricular Tachycardia, Arrhythmias, Sarcoidosis, Cardiac Ablation, and Pacemaker Implantation.

Dr. Nisha A. Gilotra is a cardiologist in the Johns Hopkins Medicine Division of Cardiology with expertise in advanced heart failure, including the care of heart transplant and ventricular assist device patients. Dr. Gilotra specializes in inflammatory cardiomyopathies, including sarcoidosis, myocarditis and inherited causes of cardiomyopathy. Dr. Gilotra received her medical degree from Jefferson Medical College in Philadelphia, PA. She completed her medical residency, general cardiology fellowship and advanced heart failure fellowship at Johns Hopkins University School of Medicine. Between fellowships, she served as an Assistant Chief of Service for the Department of Medicine. Dr. Gilotra is rated as an Elite provider by MediFind in the treatment of Sarcoidosis. Her top areas of expertise are Sarcoidosis, Myocarditis, Cardiomyopathy, Heart Transplant, and Endoscopy.

David Moller is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Moller is rated as an Elite provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Interstitial Lung Disease, and Acute Interstitial Pneumonia.

Matthew Lammi, MD MSCR is an Associate Professor of Medicine and part of the Interstitial Lung Disease (ILD) Program. Dr. Lammi obtained his medical degree from Temple University School of Medicine and did his internal medicine, pulmonary, and critical care training at Temple University Hospital. He then joined the faculty at LSU in New Orleans, where he served as the Director of the Comprehensive Pulmonary Hypertension Center. He joined Johns Hopkins in 2023. He currently serves as the Associate Director of the Johns Hopkins Pulmonary Fibrosis Foundation Care Center and is the Associate Program Director for the Advanced Lung Disease Fellowship. His research focuses on the intersection between ILD and pulmonary hypertension, particularly in patients with systemic sclerosis. He is currently a co-Principal Investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is active in numerous societies and serves as the Chair of the Research Committee for the Pulmonary Hypertension Association. Dr. Lammi is rated as an Elite provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Pulmonary Hypertension, Sarcoidosis, Systemic Sclerosis (SSc), Interstitial Lung Disease, and Lung Transplant.

Dr. Howard Steiner is an instructor of medicine at the Johns Hopkins School of Medicine. He has been practicing pulmonary and sleep consultative medicine since 1989. In his role as a diagnostician, he guides the evaluation and management of respiratory problems including infectious, malignant, allergic, autoimmune, and sleep-related disorders. He has been part-time faculty in the Johns Hopkins Pulmonary Division since 1991, is a Fellow in the American College of Chest Physicians, and mentors medical students, residents, and pulmonary fellows training at the Johns Hopkins Hospital. Contact for Research Inquiries 10755 Falls Road Pavilion I, Suite 200 Lutherville, MD 21093 Phone: (410) 583-7124 Selected Publications Lwebuga-Mukasa JS, Steiner H. Monoclonal antibody to rat lung Maclura Pomifera agglutinin (MPA) lectin binding glycoprotein localizes apically on rat and human type II pneumocytes and Clara cells. J Cell Biol 107:71a, 1989. Roberts PJ, McBean GJ, Steiner H, Kohler C, Schwarcz R. Lesioning Effects of Ibotenate in the immature rat brain and protection by 2-amino-7 phosphonoheptanoic acid. Soc Neurosci Abst 9:261, 1983. Steiner H, Ingbar DI. Mechanisms of lung injury and repair. In: Matthay RA, Matthay MA, Wiedemann HP eds. Annual Review of Pulmonary and Critical Care Medicine. Hanley & Belfus (Philadelphia, 1989), pp 205-223. Steiner H, Lwebuga-Mukasa JS. A549 cells display distinct functional and morphologic properties depending on their culture substratum. J Cell Biol 107:71a, 1989. Steiner H, Lwebuga-Mukasa JS. A549 cells produce a factor which is Mitogenic for human lung fibroblasts. Amer Rev Resp Dis 139:A492 1989. Steiner H, McBean GJ, Kohler C, Roberts PJ, Schwarcz R. Ibotenate Induced neuronal degeneration in immature rat brain. Brain Research 307:117-124, 1984. Dr. Steiner is rated as an Advanced provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Bronchiectasis, Obstructive Sleep Apnea, Lung Metastases, and Interstitial Lung Disease.

Stacey-ann Brown is a Pulmonary Medicine provider in Lutherville, Maryland. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Sarcoidosis. Her top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Hypersensitivity Pneumonitis, and Cholesterol Pneumonia.

Sam Serafi is a Rheumatologist in Baltimore, Maryland. Dr. Serafi is rated as an Experienced provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Fibromyalgia, Raynaud Phenomenon, Sjogren Syndrome, and Rheumatoid Arthritis (RA).

Tazeen Rehman is a Rheumatologist in Baltimore, Maryland. Dr. Rehman is rated as an Experienced provider by MediFind in the treatment of Sarcoidosis. Her top areas of expertise are Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis (RA), and Fibromyalgia.

Howard Hauptman is a Rheumatologist in Baltimore, Maryland. Dr. Hauptman has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Sjogren Syndrome, and Polymyalgia Rheumatica. Dr. Hauptman is currently accepting new patients.

Seema Patel is a Rheumatologist in Baltimore, Maryland. Dr. Patel has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Sarcoidosis. Her top areas of expertise are Fibromyalgia, Raynaud Phenomenon, Rheumatoid Arthritis (RA), and Discoid Lupus Erythematosus (DLE).

Bansari Gujar is a Rheumatologist in Baltimore, Maryland. Dr. Gujar is rated as an Experienced provider by MediFind in the treatment of Sarcoidosis. Her top areas of expertise are Rheumatoid Arthritis (RA), Fibromyalgia, Psoriatic Arthritis, and Psoriasis.

Edward K. Kasper, M.D. is a graduate of the Johns Hopkins University with a B.A. in Natural Sciences. He earned his M.D. at the University of Connecticut School of Medicine in 1984. His internship and residency in Internal Medicine, as well as his fellowship in Cardiovascular Medicine, were completed at the Johns Hopkins Hospital, where he then joined the faculty in 1993. He is a fellow of the American Heart Association as well as a fellow of the American College of Cardiology, having served on its board of governors from 2002 to 2006. Dr. Kasper has authored more than 100 articles and three books including, Living Well with Heart Failure. He is currently the Director of Outpatient Cardiology. Dr. Kasper's current research interests focus on the biological origins of heart failure. Specifically, his research has focused on causes and prognosis of patients with cardiomyopathy, a serious condition in which the heart has difficulty pumping blood throughout the body. Dr. Kasper works closely with his team at the Johns Hopkins Heart and Vascular Institute to understand the best ways to predict and prevent catastrophic cardiac events. With your support, Dr. Kasper will be able to continue his significant work in cardiovascular medicine in hopes of impacting the future of patients with cardiomyopathy and heart failure. Dr. Kasper is rated as a Distinguished provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Sengers Syndrome, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as a Distinguished provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis.

Dr. Michelle Sharp practices Pulmonary and Critical Care Medicine. Her primary area of interest is sarcoidosis, and she has experience in the diagnosis and treatment of sarcoidosis in all of its forms, and the management of consequences of this systemic disease. The Johns Hopkins Sarcoidosis Clinic serves to coordinate management of patients with multi-organ involvement with sarcoidosis, and to this end Dr. Sharp maintains clinical and research collaborations with Cardiology, Neurology, and Ophthalmology. Dr. Sharp received her B.S. from Tulane University. She earned her M.D. from the Louisiana State University School of Medicine. She completed her residency and fellowship in pulmonary and critical care medicine at Johns Hopkins. Dr. Sharp is rated as a Distinguished provider by MediFind in the treatment of Sarcoidosis. Her top areas of expertise are Neurosarcoidosis, Sarcoidosis, Necrotizing Granuloma, and Lung Metastases.

Dr. Stacy Fisher is a cardiologist in Baltimore, Maryland specializing in the care of adult congenital heart disease, pregnancy-related heart disease and congenital heart pulmonary hypertension. She is Associate Director of the Adult Congenital Heart Disease (ACHD) Center at the Johns Hopkins Heart and Vascular Institute and Director of the ACHD Training Program. She is also an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. Her research focus is congenital heart disease in adults including pulmonary hypertension, inherited heart disease and 3D printing translational medicine. She is interested in imaging and using 3D modeling to advance cardiac care and education. Her education includes a Bachelor of Science degree in Microbiology from Miami University in Oxford, Ohio, and a Doctor of Medicine Degree from the University of Maryland School of Medicine in Baltimore, Maryland. She completed an internship and residency in Internal Medicine at Duke University in Durham, North Carolina. Her fellowship in cardiology was at the University of Rochester, Strong Memorial Hospital in Rochester, New York, including serving as the Chief Cardiology Fellow. She was then an Adult Congenital Heart Fellow at the University of Rochester, Strong Memorial Hospital. After completing her fellowship in 2001, she joined a Baltimore cardiology practice and was named Director of Women’s Cardiovascular Services and the Co-Director of the Cardiac Critical Care Unit at Sinai Hospital in Baltimore, positions which she held until 2011. She then joined University of Maryland School of Medicine as Director of Women’s and Complex Heart diseases where she started and directed the Adult Congenital Heart Program and practiced through 2022 when she joined Johns Hopkins. She was recently the President of the American Heart Association’s Greater Maryland Region. Videos Dr. Stacy Fisher. Dr. Fisher is rated as an Experienced provider by MediFind in the treatment of Sarcoidosis. Her top areas of expertise are Familial Ventricular Tachycardia, Arrhythmias, Ventricular Tachycardia, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as an Experienced provider by MediFind in the treatment of Sarcoidosis. Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Peripartum Cardiomyopathy, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Stacey Schott, M.D., M.P.H., is a preventive cardiologist and an assistant professor in the cardiovascular division at the Johns Hopkins University School of Medicine. She specializes in preventive cardiology, cardiovascular disease, heart disease, echocardiography and nuclear cardiology. Dr. Schott is a member of the Academy of Communication in Healthcare, an organization committed to improving relationship-centered health care communication. She is also a member of The American Society for Preventive Cardiology and the American College of Preventive Medicine. Dr. Schott’s research focuses on preventive cardiology, cardiovascular disease and health care communication. Dr. Schott is rated as an Experienced provider by MediFind in the treatment of Sarcoidosis. Her top areas of expertise are Heart Failure, Heart Attack, Apoplexy, and Inappropriate Sinus Tachycardia (IST).

Mitchell Schwartz is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Towson, Maryland. Dr. Schwartz is rated as an Advanced provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Lung Metastases, Hospital-Acquired Pneumonia, Atypical Pneumonia, Neurosarcoidosis, and Gastrostomy. Dr. Schwartz is currently accepting new patients.

Howard Freeland is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Freeland is rated as an Advanced provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Lung Metastases, Pulmonary Veno-Occlusive Disease, Pulmonary Hypertension, and Chronic Obstructive Pulmonary Disease (COPD).

Jamal Mikdashi is a Rheumatologist in Baltimore, Maryland. Dr. Mikdashi is rated as a Distinguished provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Sarcoidosis, Systemic Lupus Erythematosus (SLE), Neurosarcoidosis, and Cutaneous Lupus Erythematosus (CLE). Dr. Mikdashi is currently accepting new patients.